The control of hyperphosphataemia in haemodialysis patients (Journal article)

Papayianni, L./ Katopodis, K./ Kosmanou, J./ Banioti, A./ Katsaraki, A./ Palatzidou, M./ Prokopiou, F./ Betsiou, V./ Siamopoulos, K. C.


Full metadata record
DC FieldValueLanguage
dc.contributor.authorPapayianni, L.en
dc.contributor.authorKatopodis, K.en
dc.contributor.authorKosmanou, J.en
dc.contributor.authorBanioti, A.en
dc.contributor.authorKatsaraki, A.en
dc.contributor.authorPalatzidou, M.en
dc.contributor.authorProkopiou, F.en
dc.contributor.authorBetsiou, V.en
dc.contributor.authorSiamopoulos, K. C.en
dc.date.accessioned2015-11-24T19:42:13Z-
dc.date.available2015-11-24T19:42:13Z-
dc.identifier.issn1019-083X-
dc.identifier.urihttp://olympias.lib.uoi.gr/jspui/handle/123456789/24606-
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAluminum Hydroxide/*administration & dosageen
dc.subjectAntacids/*administration & dosageen
dc.subjectChronic Diseaseen
dc.subjectDrug Administration Scheduleen
dc.subjectDrug Monitoringen
dc.subject*Feeding Behavioren
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectHyperparathyroidism, Secondary/blood/*drug therapy/etiologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPhosphates/blooden
dc.subjectRenal Dialysisen
dc.subjectUremia/*complicationsen
dc.titleThe control of hyperphosphataemia in haemodialysis patientsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/9664020-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1997-
heal.abstractPatients with chronic uraemia develop various metabolic abnormalities, the most significant being the low production of vitamin D [1.25(OH)2D3] by the kidneys (1-3), hyperphosphataemia, and hypocalcaemia (4). These abnormalities, occurring usually in combination, are responsible for the pathogenesis of secondary hyperparathyroidism (HPT) (5-11). Prevention and treatment of secondary HPT can be achieved by means of administration of vitamin D and calcium. However, the above treatment is conditional on a low serum phosphorus concentration.en
heal.journalNameEDTNA ERCA Jen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.



 Please use this identifier to cite or link to this item:
http://olympias.lib.uoi.gr/jspui/handle/123456789/24606
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.